References

Armstrong DK, Bundy B, Wenzel L, et al; Gynecologic Oncology Group. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med. 2006 Jan 5;354(1):34-43.

Blanchard EM, Hesketh PJ. Nausea and Vomiting. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 8th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2008:2639−2646.

Fall-Dickson JM ,Berger AM. Oral Complications. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 8th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2008:2655−2667.

Freter CE, Perry MC. Systemic Therapy. In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG, eds. Abeloff’s Clinical Oncology. 4th ed. Philadelphia, Pa: Elsevier Churchill Livingstone; 2008:449−483.

Gullatte MM, Gaddis J. Chemotherapy. In: Varrichio CG, ed. A Cancer Source Book for Nurses. 8th ed. Sudbury, Mass: Jones and Bartlett; 2004:103−130.

Hurria A, Somlo G, Ahles T. Renaming “chemobrain”. Cancer Invest. 2007;25(6):373−377.

Itano JK, Taoka KN, eds. Core Curriculum for Oncology Nursing. 4th ed. Philadelphia, Pa: Elsevier Saunders; 2005.

Kirby JS, Miller CJ. Intralesional chemotherapy for nonmelanoma skin cancer: A practical review. J Am Acad Dermatol. 2010 May 31. [Epub ahead of print]

Macklin DC. Developing a Patient-Centered Approach to Vascular Access Device Selection. Medscape Nurses, 08/17/2005. Accessed at www.medscape.com/viewarticle/508093_1 on August 18, 2011.

Mori T, Yamazaki R, Nakazato T, et al. Excretion of cytosine arabinoside in saliva after its administration at high doses. Anticancer Drugs. 2006;17(5):597−578.

National Cancer Institute FactSheet: Cancer Vaccines. Updated 6.21.2011. Accessed at www.cancer.gov/cancertopics/factsheet/cancervaccine on August 18, 2011.

NCCN Clinical Practice Guidelines in Oncology. Antiemesis, V.1.2012. Accessed at www.nccn.org/professionals/physician_gls/pdf/antiemesis.pdf on August 18. 2011.

NCCN Clinical Practice Guidelines in Oncology. Cancer- and Chemotherapy-Induced Anemia, V. 1.2012. Accessed at www.nccn.org/professionals/physician_gls/pdf/anemia.pdf on August 18, 2011.

Radiological Society of North America and American College of Radiology. Vascular Access Procedures. Accessed at www.radiologyinfo.org/en/info.cfm?pg=vasc_access on August 18, 2011.

Ruiz ME, Fagiolino P, M de Buschiazzo P, Volonté MG. Is saliva suitable as a biological fluid in relative bioavailability studies? Analysis of its performance in a 4 × 2 replicate crossover design. Eur J Drug Metab Pharmacokinet. 2011 Jun 30.

Sung L, Nathan PC, Alibhai SM, et al. Meta-analysis: effect of prophylactic hematopoietic colony-stimulating factors on mortality and outcomes of infection. Ann Intern Med. 2007;147(6):400−411.

US Food and Drug Administration. Information on Erythropoiesis-Stimulating Agents (ESA) Epoetin alfa (marketed as Procrit, Epogen), Darbepoetin alfa (marketed as Aranesp). Accessed at www.fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm109375.htm on August 18, 2011.

Weiss RB. Miscellaneous toxicities. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 7th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2005:2602−2614.

Yarbro CH, Frogge MH, Goodman M. Cancer Nursing: Principles and Practice. 6th ed. Sudbury, Mass: Jones and Bartlett; 2005.